Nanobiosciences and Nanopharmacology Division, Biomaterials and Biotechnology in Animal Health Lab, Department of Animal Health and Management, Science Campus 6th Floor, Alagappa University, Karaikudi, 630004, Tamil Nadu, India.
Nanobiosciences and Nanopharmacology Division, Biomaterials and Biotechnology in Animal Health Lab, Department of Animal Health and Management, Science Campus 6th Floor, Alagappa University, Karaikudi, 630004, Tamil Nadu, India; Marine College, Shandong University, Weihai, 264209, PR China.
Microb Pathog. 2020 Nov;148:104277. doi: 10.1016/j.micpath.2020.104277. Epub 2020 May 28.
SARS-CoV-2 is a causative agent of Coronavirus disease-19 (COVID-19), which is considered as a fatal disease for public health apprehension worldwide. This pathogenic virus can present everywhere. As it is a virus it can extend easily and cause severe illness to humans. Hence, an efficient international attentiveness of plan is necessary to cure and prevent. In this review, epidemic outbreak, clinical findings, prevention recommendations of COVID-19 and suggestive medicinal value of south Indian plant sources have been discussed. Though the varieties of improved approaches have been taken in scientific and medicinal concern, we have to pay attention to the medicinal value of the plant-based sources to prevent these types of pandemic diseases. This is one of the suggestive and effective ways to control the spreading of viruses. In the future, it is required to provide medicinal plant-based clinical products (Masks, sanitizers, soap, etc.,) with better techniques by clinicians to contend the scarcity and expose towards the nature-based medicine rather than chemical drugs. This may be a benchmark for the economical clinical trials of specific plant material to treat the viral diseases in the future.
SARS-CoV-2 是导致新型冠状病毒肺炎（COVID-19）的病原体，被认为是全球公共卫生关注的致命疾病。这种致病病毒无处不在。由于它是一种病毒，很容易传播，会导致人类重病。因此，需要制定有效的国际防治计划。在这篇综述中，讨论了 COVID-19 的疫情爆发、临床发现、预防建议以及南印度植物源的药用价值。尽管在科学和医学方面已经采取了各种改进方法，但我们必须关注植物来源的药用价值，以预防这类大流行病。这是控制病毒传播的一种有效方式。未来，临床医生需要通过更好的技术提供基于药用植物的临床产品（口罩、消毒剂、肥皂等），以应对短缺问题，并更多地采用基于自然的药物，而不是化学药物。这可能是未来针对特定植物材料治疗病毒疾病进行经济临床试验的基准。
